Form 4 for PCVX Vaxcyte, Inc.
Accepted 2024-06-05 00:00:00 ET · period of report 2024-06-03 · accession 0001415889-24-015590 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-06-05 | 2024-06-03 | PCVX | Gilbert Halley E | Dir | S - Sale+OE | $73.00 | -18.2K | 5,625 | -76% | -$1.33M |
| D | 2024-06-05 | 2024-06-03 | PCVX | Gilbert Halley E | Dir | M - OptEx | $5.35 | +18.2K | 23.8K | +324% | +$97.4K |
| D | 2024-06-05 | 2024-06-03 | PCVX | Gilbert Halley E | Dir | M - OptEx | $0.00 | -18.2K | 30.4K | -37% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-06-03 | S | D | 18,200 | $73.00 | 5,625 | D | — | — | |
| 2 | Common | Common Stock | 2024-06-03 | M | A | 18,200 | $5.35 | 23,825 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy) | 2024-06-03 | M | D | 18,200 | $0.00 | 30,374 | D | $5.35 · — to 2030-04-17 | 18,200 Common Stock | (F3) Reporting Person has transferred 30,374 vested stock options to Reporting Person's ex-spouse pursuant to a "domestic relations order" as defined in Section 16(a)(12) of the Securities Exchange Act of 1934, as amended. Accordingly, Reporting Person will not report beneficial ownership of or dispositions or acquisitions of the underlying shares in future Section 16(a) filings. (F2) Option is fully vested and exercisable. |